We are live on ! Find out more
KIDS icon

OrthoPediatrics

122 hedge funds and large institutions have $467M invested in OrthoPediatrics in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 37 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

15,300% more call options, than puts

Call options by funds: $462K | Put options by funds: $3K

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

11% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 37

1% more funds holding

Funds holding: 121122 (+1)

1% more capital invested

Capital invested by funds: $464M → $467M (+$3.43M)

0.65% more ownership

Funds ownership: 67.51%68.16% (+0.65%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
122
Holders Change
+1
Holders Change %
+0.83%
% of All Funds
1.76%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
20
Increased
41
Reduced
37
Closed
18
Calls
$462K
Puts
$3K
Net Calls
+$459K
Net Calls Change
+$841K
Name Holding Trade Value Shares
Change
Change in
Stake
KCM
26
Kennedy Capital Management
Missouri
$3.03M +$184K +6,006 +6%
Bank of America
27
Bank of America
North Carolina
$2.85M +$1.45M +47,185 +91%
FG
28
Formula Growth
Quebec, Canada
$2.46M -$458K -14,950 -15%
Goldman Sachs
29
Goldman Sachs
New York
$2.14M +$1.49M +48,580 +189%
Commonwealth Equity Services
30
Commonwealth Equity Services
Massachusetts
$2.1M +$12.9K +420 +0.6%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.98M +$272K +8,887 +15%
HCA
32
Harbor Capital Advisors
Illinois
$1.93M +$1.78M +58,104 +649%
PCIA
33
Prime Capital Investment Advisors
Kansas
$1.8M -$460 -15 -0%
CCA
34
Conestoga Capital Advisors
Pennsylvania
$1.39M -$5.52K -180 -0.4%
UOC
35
UBS O'Connor
Illinois
$1.38M -$512K -16,717 -26%
Citadel Advisors
36
Citadel Advisors
Florida
$1.2M -$2.09M -68,336 -62%
TIM
37
Triodos Investment Management
Netherlands
$1.19M +$15.3K +500 +1%
N
38
Nuveen
North Carolina
$1.08M
MOACM
39
Mutual of America Capital Management
New York
$1.05M -$48.3K -1,576 -4%
Swiss National Bank
40
Swiss National Bank
Switzerland
$943K +$18.4K +600 +2%
SEI Investments
41
SEI Investments
Pennsylvania
$884K +$731K +23,841 +345%
Jane Street
42
Jane Street
New York
$881K +$499K +16,279 +113%
KCM
43
Kornitzer Capital Management
Kansas
$819K
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$765K +$130K +4,245 +19%
BTI
45
Blue Trust Inc
Georgia
$737K
Tudor Investment Corp
46
Tudor Investment Corp
Connecticut
$650K -$724K -23,609 -51%
LFG
47
Larson Financial Group
Missouri
$560K
CS
48
Candriam SCA
Luxembourg
$551K +$146K +4,767 +33%
DSCM
49
Divisadero Street Capital Management
Florida
$514K +$548K +17,864 New
Legal & General Group
50
Legal & General Group
United Kingdom
$484K +$45K +1,468 +10%

KIDS Hedge Fund Activity: Q2 2024 in Review

122 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in OrthoPediatrics (KIDS) for Q2 2024, worth a combined $467M — up 0.74% from $464M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new KIDS positions and 18 closed out — a net gain of 2 holders — while 41 added to existing stakes and 37 trimmed.

The largest buyer was Soleus Capital Management, opening a new position worth an estimated $9.49M. The largest seller was ExodusPoint Capital Management, exiting entirely with an estimated $6.77M sold.

  • 122 institutional investors held OrthoPediatrics (KIDS) as of Q2 2024, up from 121 in Q1 2024.
  • Funds reported $467M of OrthoPediatrics stock for Q2 2024, up 0.74% quarter-over-quarter.
  • 20 funds opened new OrthoPediatrics positions in Q2 2024 and 18 closed out, a net change of +2 holders.
  • The largest OrthoPediatrics buyer in Q2 2024 was Soleus Capital Management, an estimated $9.49M added.
  • The largest OrthoPediatrics seller in Q2 2024 was ExodusPoint Capital Management, an estimated $6.77M sold.

Based on aggregated 13F filings for Q2 2024.